About Per Langoe
Per Langoe is a chief executive officer and director at GT Medical Technologies.
Per Langoe first appears on SEC filings in 2024.
Experience
This experience comes from Per Langoe's profile and from SEC filings. For roles taken from filings, the years are when the filings name Per Langoe in the role, so the role may have started earlier or lasted longer.
GT Medical Technologies, Inc. Current
Chief Executive Officer and director
2024 – Present · Tempe, AZ
Makes radiation implants for patients undergoing brain tumor surgery.
PA
ProstaLund AB
Chairman of the Board
2023 – 2025
PS
Palette Life Sciences
President and Chief Executive Officer
2018 – 2023
LL
Langoe Strategic Advisors, LLC
Partner
2017 – 2023
AI
AdvaVet Inc
Chairman of the Board
2018 – 2019
OA
Oasmia Pharmaceutical AB
Member Board of Directors
2017 – 2019
NE
Nestlé
Head of M&A, Nestle Skin Health
2015 – 2018
PA
Pharmanest AB
Member Board of Directors
2012 – 2018
GA
Galderma
Head of Global Marketing Aesthetic&Corrective business
2011 – 2013
QA
Q-Med AB
Senior Director Corporate Development and Strategy
2003 – 2011
OA
OTRE AB
Executive Vice President
2000 – 2002
PU
Pharmacia & Upjohn
Senior Product Manager
1995 – 2000
Key Colleagues at Startups
The people Per Langoe works with at each company, as listed on that company's latest Form D.
GT Medical Technologies, Inc. · Form D, Jul 22, 2026
SA
Susana Amorim
Director
JR
Jason Rostovsky
Director
PL
Prattipati Laxminarain
Executive officer and director
James Leech
Chief Financial and Strategy Officer
PE
Paul Enever
Director
KD
Kyle Dempsey
Director
David Brachman
Co-Founder and Chief Technology Officer, director